Deltec Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Deltec Asset Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-500,000	Closed	-$135K	–	201
2016 Q3	$135K	Sell	500,000 -250,000	-33%	-$63.3K	0.03%	145
2016 Q2	$180K	Sell	750,000 -248,000	-25%	-$42.6K	0.05%	133
2016 Q1	$114K	Hold	998,000	–	–	0.03%	131
2015 Q4	$112K	Sell	998,000 -979,454	-50%	-$138K	0.03%	138
2015 Q3	$376K	Buy	1,977,454 +866,782	+78%	+$295K	0.09%	130
2015 Q2	$777K	Buy	1,110,672 +865,056	+352%	+$598K	0.17%	82
2015 Q1	$167K	Sell	245,616 -1,000	-0.4%	-$699	0.04%	134
2014 Q4	$195K	Sell	246,616 -53,384	-18%	-$36.5K	0.04%	127
2014 Q3	$140K	Hold	300,000	–	–	0.03%	136
2014 Q2	$150K	Hold	300,000	–	–	0.03%	140
2014 Q1	$93K	Sell	300,000 -150,000	-33%	-$55.8K	0.02%	144
2013 Q4	$153K	Buy	450,000 +390,975	+662%	+$472K	0.04%	134
2013 Q3	$119K	Hold	59,025	–	–	0.03%	133
2013 Q2	$112K	Buy	+59,025	New	+$104K	0.03%	137

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BCM

Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Deltec Asset Management's GCVRZ Position: Q4 2016 in Review

Deltec Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2016, closing a stake of 500,000 shares — an estimated $135K sold.

Deltec Asset Management first reported a position in GCVRZ in Q2 2013 and held it in 14 quarters. The position peaked at $777K in Q2 2015. 120 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2016.

Deltec Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2016 after selling out during the quarter.
Deltec Asset Management sold 500,000 Sanofi Contingent Value Rights shares in Q4 2016, an estimated $135K.
Deltec Asset Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 14 quarters.
Deltec Asset Management's Sanofi Contingent Value Rights position peaked at $777K in Q2 2015.
120 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2016.

Based on Deltec Asset Management's 13F filing for Q4 2016, filed 20 Jan 2017.